Senior Management

Our senior management team works tirelessly to create an environment where excellent research thrives. They lead our administration and corporate services, facilities, IT and research services teams and provide our researchers with the specialized support that enables innovative research.

Senior Executive Director, Research
Dr. Quynh Doan
Executive Coordinator: Erika Kosuge, 604-875-2404

Associate Director, Research Community
Dr. Wendy Robinson

Executive Director, Research Administration and Operations
Vicki Chiu
604-875-2488
Executive Coordinator: Erika Kosuge, 604-875-2404

Clinical Research
Dr. Quynh Doan, Director
Executive Coordinator: Erika Kosuge, 604-875-2404

Research Communications
Dr. Alan Worsley, Interim Manager
604-219-4685

Research Ethics Board
Jennie Prasad, Director
604-875-2441
Administrative Coordinator: Talysa Dhahan, 604-875-3013

Research Facilities
Todd Jacques, Director
604-875-2409
Administrative Assistant: Tracy Aomoto, 604-875-2000 ext. 2435

Research Finance
Kelly Chan, Senior Manager
604-875-2000 ext. 6771

Research Informatics
Dr. Tibor van Rooij, Director
250-686-2934

Research IT
Robert Chrisp, Manager
604-875-2000 ext. 4958
Administrative Coordinator: Twinky Ip, 604-875-2000 ext. 5433

Research & Technology Development Office
Dr. Dawn McArthur, Director
604-875-3105

Research Services
Isabelle Linden, Director
604-875-2000 ext. 2108

Get Involved

We need you today for a better tomorrow. Our kids are counting on it.

Get involved

Recent News See all

BCCHR research could help set new international standard for young children receiving bone marrow transplants

The findings from a BCCHR study played a part in integrating the multiple breath washout test into recent recommendations to screen children for pulmonary chronic graft-versus-host disease, a lung complication that can affect children who undergo a bone marrow transplant.

Continue reading BCCHR research could help set new international standard for young children receiving bone marrow transplants

Beyond access: Moving towards equity in pediatric type 1 diabetes care

Managing type 1 diabetes (T1D) can be challenging for patients, especially those from marginalized populations facing structural inequities. Families affected by T1D often grapple with managing a complex condition that requires continuous monitoring, timely insulin administration, and strict adherence to treatment plans. These challenges can be exacerbated for patients in socioeconomically deprived communities, where access to care and diabetes technology is often limited.

Continue reading Beyond access: Moving towards equity in pediatric type 1 diabetes care

New study makes key findings in potential advancement of diabetes cure

New research published in Nature Communications, identifies a key molecule that might be critical for the development of stem cell-based therapies for treating type 1 diabetes.

Continue reading New study makes key findings in potential advancement of diabetes cure

Pneumonia and malaria: Innovations tackle leading threats to children under five

Globally, pneumonia and malaria are among the leading causes of death for children under five, due in part to health-care resource gaps in low- and middle-income countries. New BCCHR investigator and pediatric infectious diseases expert Dr. Michael T. Hawkes is developing diagnostic and treatment tools to address these shortages.

Continue reading Pneumonia and malaria: Innovations tackle leading threats to children under five

Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Dr. Kirk Schultz, an investigator at BC Children’s Hospital Research Institute, has been awarded the 2024 Geoffrey L. Hammond Lectureship in recognition of his leadership and significant contributions to improving the health and well-being of children in British Columbia and around the world.

Continue reading Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Donate to Research

We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.

Give Now